ENTPD1 and cancer: NTPDase1 inhibitors may therefore represent a valuable tool to potentiate various physiological actions of nucleotides and could also serve as potential drug candidates for the treatment of some diseases associated with functions of NTPDase1 such as in cardiovascular [11, 22, 27] and immune diseases [23, 30] and cancer [31, 32].